Report Company Directory
- NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement Pathway by GlobeNewsWire
- NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives by GlobeNewsWire
- NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain by GlobeNewsWire
- NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives by GlobeNewsWire
- NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues by GlobeNewsWire
- NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025 by GlobeNewsWire
- NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population by GlobeNewsWire
- NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 by GlobeNewsWire
- NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues by GlobeNewsWire
- NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025 by GlobeNewsWire